Cells and xenografts

AG A. Ganguli
AO A. Ornob
NS N. Spegazzini
YL Y. Liu
GD G. Damhorst
TG T. Ghonge
BT B. Thornton
CK C. J. Konopka
WD W. Dobrucki
SC S. E. Clare
RB R. Bhargava
AS A. M. Smith
FK F. Kosari
RB R. Bashir
request Request a Protocol
ask Ask a question
Favorite

LNCaP prostate cancer cells were obtained from and verified by the American Type Culture Collection (ATCC). The cells were cultured per the recommended standard in a 37 °C humidified incubator with 5% CO2 atmosphere.

LNCaP subcutaneous xenografts were grown in immunocompromised nude mice (Jackson Laboratory). LNCaP cells were first incubated and grown to confluence. Then, these confluent cells were suspended in 10% Matrigel at a concentration of 2 × 107 cells/60 μL and 60 μL of this Matrigel–cell solution was injected subcutaneously into both flanks of the animal. The mice were then monitored daily for the presence of tumors. As soon as tumors were visible, volume measurements were taken using digital calipers twice a week, and tumor volumes were calculated using the formula volume = (length × width2)/2. Once tumors reached 50,000 mm3 in volume, the mice were sacrificed by overdosing with isofluorane anesthesia, after which the tumors were immediately excised and divided to be placed in optimal cutting temperature compound (OCT), or 4% PFA. All animal experiments were performed according to the guiding principles of the American Physiologic Society and approved by the Institutional Animal Care and Use Committee (IACUC protocol #17106—Dobrucki, PI) at the University of Illinois at Urbana-Champaign.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A